| 11/03/24 | 07:00:03 | 11 Mar 2024 | | £700,500 Subscription | RNS |
| 20/02/24 | 16:31:57 | 20 Feb 2024 | | Holding(s) in Company | RNS |
| 06/02/24 | 07:00:03 | 6 Feb 2024 | | Operations Update | RNS |
| 01/02/24 | 10:44:50 | 1 Feb 2024 | | Holding(s) in Company | RNS |
| 31/01/24 | 13:05:39 | 31 Jan 2024 | | Holding(s) in Company | RNS |
| 30/01/24 | 07:00:07 | 30 Jan 2024 | | Positive Soil and Grab Results at West Huntoon | RNS |
| 23/01/24 | 07:00:07 | 23 Jan 2024 | | Huntoon Mine Area Cooperation Agreement | RNS |
| 12/01/24 | 07:00:02 | 12 Jan 2024 | | Holding(s) in Company | RNS |
| 12/01/24 | 07:00:01 | 12 Jan 2024 | | Holding(s) in Company | RNS |
| 10/01/24 | 07:00:04 | 10 Jan 2024 | | Mill Site Update | RNS |
| 14/12/23 | 07:00:15 | 14 Dec 2023 | | Extended Gold Zone at M5 | RNS |
| 24/11/23 | 07:00:09 | 24 Nov 2023 | | Change of Auditor | RNS |
| 16/11/23 | 07:00:10 | 16 Nov 2023 | | Copper Potential Materially Upgraded | RNS |
| 14/11/23 | 07:00:10 | 14 Nov 2023 | | Mill Site Progress & 121 Mining Investment Forum | RNS |
| 06/11/23 | 07:00:13 | 6 Nov 2023 | | Significant Mesodermal Killer Cell Milestone | RNS |
| 18/10/23 | 15:24:04 | 18 Oct 2023 | | Total Voting Rights | RNS |
| 13/10/23 | 12:00:01 | 13 Oct 2023 | | Holding(s) in Company | RNS |
| 27/09/23 | 07:00:06 | 27 Sept 2023 | | Interim Results to 30 June 2023 | RNS |
| 27/09/23 | 07:00:04 | 27 Sept 2023 | | Half-year Report | RNS |
| 22/09/23 | 11:42:40 | 22 Sept 2023 | | Investor Presentation via Investor Meet Company | RNS |
| 12/09/23 | 07:00:01 | 12 Sept 2023 | | Mill Site Progress | RNS |
| 22/08/23 | 07:00:05 | 22 Aug 2023 | | Mill Construction Update | RNS |
| 14/08/23 | 07:00:04 | 14 Aug 2023 | | Expansion of Patent Portfolio | RNS |
| 08/08/23 | 13:50:53 | 8 Aug 2023 | | Holding(s) in Company | RNS |
| 08/08/23 | 13:48:21 | 8 Aug 2023 | | Holding(s) in Company | RNS |
| 07/08/23 | 07:00:05 | 7 Aug 2023 | | Development of New Novel siRNA Therapeutics | RNS |
| 02/08/23 | 07:00:07 | 2 Aug 2023 | | Director/PDMR Shareholding | RNS |
| 26/07/23 | 07:00:07 | 26 Jul 2023 | | Placing of New Ordinary Shares | RNS |
| 12/07/23 | 10:27:25 | 12 Jul 2023 | | Director/PDMR Shareholding | RNS |
| 10/07/23 | 07:00:02 | 10 Jul 2023 | | Exploration Update | RNS |
| 05/07/23 | 14:37:35 | 5 Jul 2023 | | Holding(s) in Company | RNS |
| 29/06/23 | 10:05:01 | 29 Jun 2023 | | Results of AGM | RNS |
| 29/06/23 | 07:00:02 | 29 Jun 2023 | | AGM Statement | RNS |
| 27/06/23 | 07:00:05 | 27 Jun 2023 | | Investor Presentation via Investor Meet Company | RNS |
| 26/06/23 | 14:41:29 | 26 Jun 2023 | | Director/PDMR Shareholding | RNS |
| 26/06/23 | 10:36:26 | 26 Jun 2023 | | Director/PDMR Shareholding | RNS |
| 26/06/23 | 10:00:10 | 26 Jun 2023 | | Director/PDMR Shareholding | RNS |
| 22/06/23 | 07:00:08 | 22 Jun 2023 | | RNA Medicine Shows In Vitro Anti-Cancer Efficacy | RNS |
| 19/06/23 | 07:00:04 | 19 Jun 2023 | | Antibody Program Results & Orphan Drug Indication | RNS |
| 13/06/23 | 12:00:01 | 13 Jun 2023 | | Result of AGM | RNS |
| 13/06/23 | 07:00:12 | 13 Jun 2023 | | Anti-Cancer MDK mRNA - Positive in vitro Results | RNS |
| 12/06/23 | 07:48:42 | 12 Jun 2023 | | Updated dial-in details for AGM | RNS |
| 07/06/23 | 10:11:46 | 7 Jun 2023 | | Restoration of Trading | RNS |
| 06/06/23 | 07:00:08 | 6 Jun 2023 | | Notice of Annual General Meeting | RNS |
| 06/06/23 | 07:00:04 | 6 Jun 2023 | | Gold & Silver Processing Update | RNS |
| 05/06/23 | 07:00:07 | 5 Jun 2023 | | Annual Report & Financial Statements - 31 Dec 2022 | RNS |
| 19/05/23 | 07:00:04 | 19 May 2023 | | Notice of AGM | RNS |
| 18/05/23 | 07:00:05 | 18 May 2023 | | Final Results | RNS |
| 02/05/23 | 07:56:14 | 2 May 2023 | | Suspension of Trading Pending 2022 Annual Report | RNS |
| 30/03/23 | 07:00:04 | 30 Mar 2023 | | Operational Update | RNS |
